Correlation Between Solid Biosciences and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Solid Biosciences and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solid Biosciences and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solid Biosciences LLC and X4 Pharmaceuticals, you can compare the effects of market volatilities on Solid Biosciences and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solid Biosciences with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solid Biosciences and X4 Pharmaceuticals.
Diversification Opportunities for Solid Biosciences and X4 Pharmaceuticals
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Solid and XFOR is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Solid Biosciences LLC and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Solid Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solid Biosciences LLC are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Solid Biosciences i.e., Solid Biosciences and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Solid Biosciences and X4 Pharmaceuticals
Given the investment horizon of 90 days Solid Biosciences is expected to generate 1.69 times less return on investment than X4 Pharmaceuticals. But when comparing it to its historical volatility, Solid Biosciences LLC is 3.76 times less risky than X4 Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 50.00 in X4 Pharmaceuticals on September 1, 2024 and sell it today you would lose (11.00) from holding X4 Pharmaceuticals or give up 22.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Solid Biosciences LLC vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Solid Biosciences LLC |
| X4 Pharmaceuticals |
Solid Biosciences and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Solid Biosciences and X4 Pharmaceuticals
The main advantage of trading using opposite Solid Biosciences and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solid Biosciences position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |